Morphological and Biochemical Features Affecting the Antithrombotic Properties of the Aorta in Adult Rabbits and Rabbit Pups

E. Nitschmann; L. Berry; S. Bridge; M. W. C. Hatton; M. Richardson; P. Monagle; A. K. C. Chan; M. Andrew

doi:10.1055/s-0037-1615116

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1998; 79(05): 1034-1040
DOI: 10.1055/s-0037-1615116

Review Article

Schattauer GmbH

Morphological and Biochemical Features Affecting the Antithrombotic Properties of the Aorta in Adult Rabbits and Rabbit Pups

Authors

E. Nitschmann

¹From the Hamilton Civic Hospitals Research Center, Hamilton, Ontario

²From the Department of Pediatrics, McMaster University, Hamilton, Ontario
L. Berry

¹From the Hamilton Civic Hospitals Research Center, Hamilton, Ontario

²From the Department of Pediatrics, McMaster University, Hamilton, Ontario
S. Bridge

¹From the Hamilton Civic Hospitals Research Center, Hamilton, Ontario
M. W. C. Hatton

³From the Department of Pathology, McMaster University, Hamilton, Ontario, Canada
M. Richardson

³From the Department of Pathology, McMaster University, Hamilton, Ontario, Canada
P. Monagle

¹From the Hamilton Civic Hospitals Research Center, Hamilton, Ontario
A. K. C. Chan

¹From the Hamilton Civic Hospitals Research Center, Hamilton, Ontario

²From the Department of Pediatrics, McMaster University, Hamilton, Ontario
M. Andrew

¹From the Hamilton Civic Hospitals Research Center, Hamilton, Ontario

²From the Department of Pediatrics, McMaster University, Hamilton, Ontario

Abstract

Summary

We hypothesised that there are important physiologic differences in arterial wall structure and function with respect to antithrombotic activity in the very young (pre-puberty) compared to adults. Electron microscopy, gel electrophoresis, and activity assays were used to examine differences in aorta structure and function comparing prepubertal rabbits (pups) to adult rabbits. Differences in endothelial function, extracellular matrix structure, proteoglycan (PG) distribution and glycosaminoglycan (GAG) content and function were shown. In both intima and media, total PG, chondroitin sulfate (CS) PG and heparan sulfate (HS) PG content were significantly increased in pups compared to adult rabbits. These findings corresponded to increased concentrations by mass analyses of CS GAG and DS GAG in aortas from pups. There was also a significant increase in antithrombin activity in pups due to HS GAG. In conclusion, differences in both structure and antithrombin activity of aortas from pups compared to adult rabbits suggest that young arteries may have greater antithrombotic potential that is, at least in part, related to increased HS GAG.

Volltext

Referenzen

References
1 Andrew M, David M, deVeber G, Brooker L. Arterial thromboembolic complications in paediatric patients. Thromb Haemost 1997; 78: 215-25.
2 Andrew M, David M, Adams M, Ali K, Anderson R, Barnard D, Berstein M, Brisson L, Cairney B, DeSai D. et al. Venous thromboembolic complications (VTE) in children: First analyses of the Canadian Registry of VTE. Blood 1994; 83 (05) 1251-7.
3 Schmidt B, Andrew M. Neonatal thrombosis: Report of a prospective Canadian and International registry. Pediatrics 1995; 96: 939-43.
4 Monnens LAH, Retera RJM. Thrombotic thrombocytopenic purpura in a neonatal infant. J Pediatr 1967; 71 (01) 118-23.
5 Rhodin J. Histology. New York: Oxford University Press; 1974. The cardiovascular system p. 332-70.
6 Hawiger J, Handin R, Nathan D, Oski F. editors. Hematology of infancy and childhood. Fourth ed. Philadelphia: W. B. Saunders; 1993: 41 Section II. Structure and function of platelets. p. 1512-33.
7 Soff G, Rosenberg R, Nathan D, Oski F. editors. Hematology of Infancy and Childhood. Fourth ed. Philadelphia: W. B. Saunders; 1993: 42 Physiology of hemostasis: The fluid phase. p. 1534-60.
8 Murata K, Horiuchi Y. Molecular weight-dependent distribution of acidic glycosaminoglycans in human plasma. Clin Chim Acta 1977; 75: 59-69.
9 Pejler G, Backstrom G, Lindahl U, Paulsson M, Dziadek M, Fujiwara S, Timpl R. Structure and affinity of heparan sulfate chains derived from basement membrane proteoglycans. J Biol Chem 1987; 262: 5036-43.
10 Tollefsen D, Petska C, Monafa J. Activation of heparin cofactor II by dermatan sulfate. J Biol Chem 1983; 256: 6713-6.
11 Hatton MWC. Evidence for thrombin binding to dermatan sulphate sites in the rabbit aorta subendothelium in vitro. Blood Coagulation and Fibrinolysis 1993; 4: 927-33.
12 Koeleman JHTM, Bakker CM, Plandsoen WCG, Peeters FLM, Barth PG. Hereditary protein S deficiency presenting with cerebral sinus thrombosis in an adolescent girl. Journal of Neurology 1992; 239: 105-6.
13 Hatton MWC, Hoogendoorn H, Southward SM, Ross B, Blajchman MA. Comparative metabolism and distribution of rabbit heparin cofactor II and rabbit antithrombin III in rabbits. Am J Physiol 1997; 272 5 Pt 1 E824-31.
14 Hatton MWC, Moar S, Richardson M. Evidence that rabbit 125-I-anti-thrombin III binds to proteoheparan sulphate at the subendothelium of the rabbit aorta in vitro. Blood Vessels 1988; 25: 12-27.
15 Bendeck MP, Keeley FW, Langille BL. Perinatal accumulation of arterial wall constituents: Relation to hemodynamic changes at birth. Am J Physiol 1994; 267: H2268-79.
16 Yla-Herttuala S, Sumuvuori H, Karkola K, Mottonen M, Nikkari T. Glycosaminoglycans in normal and atherosclerotic human coronary arteries. Lab Invest 1986; 54: 402-7.
17 Roberts CR, Pare PD. Compositional changes in human tracheal cartilage in growth and ageing, including changes in proteoglycan structure. Am J Physiol 1991; 261: L92-L101.
18 Hilgartner ME, Smith CH. Plasma thromboplastin antecedent (factor XI) in the neonate. J Pediatr 1965; 66: 747.
19 O’Brodovich H, Berry L, D’Costa M, Burrows R, Andrew M. The influence of fetal pulmonary epithelium on thrombin activity. Am J Physiol (Lung Cell Mol Physiol) 1991; 5: L262-70.
20 Fernandez F, Buchanan M, Hirsh J, Fenton J, Ofosu F. Catalysis of thrombin inhibition provides an index for estimating the antithrombotic potential of glycosaminoglycans in rabbits. Thromb Haemost 1987; 47: 286-93.
21 Idell S, James KK, Levin EG. et al. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress sydrome. J Clin Invest 1989; 84: 695-705.
22 Andrew M, Mitchell L, Paes B, Berry L, Burrows R, Khambalia B, Ofosu F. An anticoagulant dermatan sulphate proteoglycan circulates in the pregnant women and her fetus. J Clin Invest 1992; 89: 321-6.
23 van der Heiden R, Hatton MWC, Moore S. Extraction and analysis of glycosaminoglycans from intima-media of single rabbit aortae: effect of ballon catheter de-endothelialization on the content and profile of glycosaminoglycans. Atherosclerosis 1988; 73: 203-13.
24 Richardson M, Kinlough-Rathbone R, Groves H, Jorgensen L, Mustard J, Moore S. Ultrastructural changes in re-endothelialized and non-endothelialized rabbit aortic neo-intima following re-injury with a balloon catheter. Br J Exp Path 1984; 65: 597-611.
25 Moore S, Richardson M. Proteoglycan distribution in catheter-induced aortic lesions in normolipaemic rabbits. Atherosclerosis 1985; 55: 313-30.
26 Richardson M, Hatton MWC. Transient morphological and biochemical alterations of arterial proteoglycan during early wound healing. Exp Mol Pathol 1993; 58: 77-95.
27 Richardson M. Proteoglycan distribution in the intima and media of young and aging rabbits. An ultrastructural study. Arteriosclerosis 1988; 71: 243-56.
28 Richardson M, Hadcock SJ, Hatton BD, Winocour PD, Hatton MWC. Proteoglycan alterations in the aortic intima-media of alloxan-diabetic rabbits: An ultrastructural and biochemical study. Exp Mol Pathol 1993; 58: 145-59.
29 Campbell GR, Campbell JH. Smooth muscle phenotypic changes in arterial wall homeostasis: Implications for the pathogenesis of atherosclerosis. Exp Mol Pathol 1985; 42: 139-62.
30 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680.
31 Moller HJ, Heinegard D, Poulsen JH. Combined alcian blue and silver staining of sub-nanogram quantities of proteoglycans and glycosaminoglycans in sodium dodecylsulfate-polyacrylamide gels. Anal Biochem 1993; 209: 169-75.
32 Andrew M, Schmidt B, Mitchell L, Paes B, Ofosu F. Thrombin generation in newborn plasma is critically dependent on the concentration of prothrombin. Thromb Haemostas 1990; 63: 27-30.
33 Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L. Maturation of the hemostatic system during childhood. Blood 1992; 80 (08) 1998-2005.
34 Thery C, Simonneau G, Meyer G, Helenon O, Bridey F, Armagnac C, d’Azemar P, Coquart J. Randomized trial of subcutaneous low-molecular-weight heparin CY 216 (Fraxiparine) compared with intravenous unfractionated heparin in the curative treatment of submassive pulmonary embolism. A dose-ranging study. Circulation 1992; 85: 1380-9.
35 Robert L, Moczar M, Varma V. editors. Glycosaminoglycans and proteoglycans in physiological and pathological processes of body systems. Bases: Karger; 1982. Age-related changes of proteoglycans and glycosaminoglycans. p. 440-60.
36 Mitchell L, Superina R, Delorme M, Vegh P, Berry L, Hoogendoorn H, Andrew M. Circulating dermatan sulphate/heparin sulfate proteoglycan(s) in children undergoing liver transplantation. Thromb Haemost 1995; 74 (03) 859-63.
37 Andrew M, Brooker L. Hemostatic complications in renal disorders of the young. Pediatr Nephrol 1996; 10 (01) 88-99.
38 Chan AK, Baranowski B, Berry L, Liu M, Raffi B, Post M, O’Brodovich H, Andrew M. Influence of mechanical stretch on thrombin inhibition by mixed fetal lung epithelial cells. J Resp Cell Mol Biol. 1997 submitted.